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Evaluating frequency and quality
of pathogen-speciﬁc T cells
Nadia Anikeeva1, Dolores Grosso2, Neal Flomenberg2,3 & Yuri Sykulev1,2,3

It is generally accepted that enumeration and characterization of antigen-speciﬁc T cells
provide essential information about potency of the immune response. Here, we report a new
technique to determine the frequency and potency of antigen-speciﬁc CD8 T cells. The assay
measures changes of intracellular Ca2 þ in real time by ﬂuorescent microscopy in individual
CD8 T cells responding to cognate peptides. The T cells form continuous monolayer, enabling
the cells to present the peptides to each other. This approach allows us to evaluate the
kinetics of intracellular Ca2 þ signalling that characterizes the quality of T cell response. We
demonstrate the usefulness of the assay examining the frequency and quality of cytomegalovirus-speciﬁc CD8 T cells from healthy donor and patient after haploidentical stem cell
transplantation. The new assay has a potential to provide essential information determining
the status of the immune system, disease morbidity, potency of therapeutic intervention and
vaccine efﬁcacy.
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T

he frequency of pathogen-speciﬁc and tumour-speciﬁc
T cells and their functional activity reﬂect the effectiveness
of immune responses and can serve as useful diagnostic and
prognostic indicators1–3. Increase in intracellular concentration of Ca2 þ during T-cell activation appears to be a versatile
marker of responding T cells4,5 that is determined by the speciﬁcity
of responding T cells but does not depend on the stage of T-cell
differentiation and the spectrum of produced cytokines. Estimated
75% of all activation-regulated genes showed dependence on Ca2 þ
ﬂux6. This emphasizes the role of Ca2 þ signalling in regulating
early signalling events, which inﬂuence functional T-cell
responses7. Typically, Ca2 þ response of T cells induced by
antigen stimulation is evaluated by ﬂow cytometry using
intracellular Ca2 þ indicators. However, the frequency of a small
number of antigen-speciﬁc T cells is difﬁcult to detect by ﬂow
cytometry assay due to large differences in the ﬂuorescent intensity
between the individual cells within heterogeneous T-cell
population8. To overcome this drawback, we developed an
approach that measures the Ca2 þ response in individual T cells
by means of ﬂuorescent microscopy. Speciﬁcally, we utilized
CD8 þ T cells labelled with Ca2 þ -dependent ﬂuorophore and
analyzed intracellular ﬂuorescence of these T cells in monolayers
before and after stimulation with speciﬁc antigenic peptides.
Subtraction of intracellular ﬂuorescent intensity measured
before and after the stimulation at various time points revealed
responding T cells and the kinetics of intracellular Ca2 þ
accumulation. Using T-cell clones, we optimized the assay
parameters and determined the limit of detection and sensitivity
of the approach. We have found that o0.1% of responding T cells
that are capable of ﬂuxing Ca2 þ in a population of CD8 T cells
could be reliably detected. We also determined that up to 100
different peptides could be tested in one round of the assay, which
is important for testing of peptide pools in clinical applications. To
demonstrate the usefulness of the approach, we analyzed frequency
of cytomegalovirus (CMV)-speciﬁc T cells derived from peripheral
blood of healthy donor and patient who underwent haploidentical
stem cell transplantation.
In conclusion, the proposed novel assay permits examining the
frequency and quality of antigen-speciﬁc human CD8 T cells. The
new assay revealed potential diagnostic and prognostic values. It
can be utilized to derive essential information determining the
status of the immune system, disease morbidity, potency of
therapeutic intervention and vaccine efﬁcacy.
Results
Principal of the assay. All nucleated cells, including CD8 T cells
that play essential role in virus- and tumour-speciﬁc immunity,
express MHC-I proteins. Thus, the T cells could recognize
cognate peptide-MHC (pMHC) ligands on their surface, get
activated and exercise effector functions against each other9. We
exploited this essential property to identify CD8 T cells with the
speciﬁcity of interest in a population of CD8 T cells isolated from
human peripheral blood. Antigenic peptides added to the cells
rapidly bind to available MHC class I on the surface of the T cells
assembled into the monolayer resulting in appearance of cognate
pMHC recognizable by the T-cell receptor (TCR). The recognition of the cognate pMHC on T-cell surface by a neighbouring
T cell leads to Ca2 þ ﬂux in responding cells. Ca2 þ ﬂux is
detected by measuring increase of intracellular ﬂuorescent
intensity in responding T cells labelled with calcium-dependent
ﬂuorophore by means of ﬂuorescent microscopy. The difference
between initial intracellular ﬂuorescence and the ﬂuorescence
determined after the peptide addition in individual cells with
MetaMorph software reveals frequency of responding T cells in
the monolayer. The analysis of kinetics of increase in intracellular
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Figure 1 | Schematic presentation of CaFlux assay. T cells form
monolayers on the glass bottom of the well covered with antibodies against
T-cell’s surface receptors. A peptide antigen is injected into the well. The
peptide molecules bind to MHC proteins expressed on the T-cell surface to
form recognizable pMHC ligands. Each T cells can serve as a target cells for
neighbouring T cells, but only rare antigen-speciﬁc T cell is expected to
recognize and respond to deﬁned antigenic peptide used in the assay.
Recognition events induce rise in the level of intracellular Ca2 þ . To detect
Ca2 þ inﬂux, the T cells are labelled with Ca2 þ sensitive ﬂuorophore. The
changes in ﬂuorescent intensity in individual cells before and after peptide
addition are measured with ﬂuorescent microscopy to identify the
frequency of responding T cells.

Ca2 þ provides the information about efﬁciency of T-cell
response to particular antigen. The assay is termed CaFlux
assay and is schematically illustrated in Fig. 1.
The assay development. Glass bottom of 96-well plates was
covered with poly-L-Lysine to capture TS2/4 antibody recognizing LFA-1 adhesion receptor without blocking LFA-1 functional
activity. Cloned CD8 T cells with known speciﬁcity or polyclonal
CD8 T cells were labelled with Ca2 þ ﬂuorophore Fluo-4 and
added to the wells. The quality of the T-cell monolayers was
evident from analysis of bright ﬁeld images of the immobilized
T cells on the glass bottom of the plate. Figure 2a shows that
T cells form uniform and tight monolayers allowing the T cells to
contact each other, which is necessary for presentation and
recognition of pMHC on one T cell by another T cell.
To optimize the conditions of the assay, we utilized established
human clones of cytotoxic T lymphocytes (CTL) recognizing viral
peptides in association with HLA-A2 MHC class I protein
(see ‘Methods’ section). Addition of a cognate peptide to T-cell
monolayer resulted in signiﬁcant increase of intracellular
ﬂuorescent intensity of the T cells over the background indicative
of Ca2 þ inﬂux (Fig. 2b–d and Supplementary Movie 1). The
Ca2 þ inﬂux was observed in 90–95% of the T cells. The addition
of non-cognate peptide to the monolayer did not induce
intracellular Ca2 þ ﬂux (Fig. 2d and Supplementary Movie 2).
Because calcium ions distributed all over cytoplasm, bleaching of
the ﬂuorescence was not evident allowing to acquire dozens of
images from the same ﬁeld after the signalling was initiated
(Supplementary Fig. 1).
The time course of the CD8 T-cell response to agonist peptide
revealed two phases (Fig. 2d), which are usually observed in a
population of responding T cells10. The ﬁrst phase is characterized by a quick rise of intracellular Ca2 þ concentration
that reaches maximum, followed by a decrease in the Ca2 þ
level. Subsequently, the elevated level of intracellular Ca2 þ
concentration is sustained over prolong period of time.
As opposed to functional T-cell responses such as production
of cytokines or killing, Ca2 þ ﬂux can be measured at room
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Figure 2 | Detection of responding T cells in the monolayer. Cloned CD8 þ T cells CER43 labelled with Fluo-4 were attached to a glass bottom of 96-well
plates covered with poly-L-lysine via non-blocking anti-LFA-1 antibodies to form a monolayer ensuring direct contact of T cells with each other (a,b).
Addition of a strong agonist peptide GILGFVFTL (GL9) to the monolayer of the labelled T cells induced intracellular Ca2 þ ﬂux resulting in the timedependent increase of intracellular ﬂuorescence intensity that reaches maximum in 2–3 min (c,d). Addition of non-stimulatory peptide ILKEPVHGV (IV9)
did not lead to the increased of intracellular ﬂuorescence (d). Data are representative of nine independent experiments. Images (b) and (c) are taken at
time 0 and 220 s after the stimulation, respectively. The results shown on d are based on the analysis of 4,500 T cells. Scale bars, 50 mm.

a
% specific lysis

IV9

IV9-A7

IV9-A4

80
60
40
20
0

–12

–10

–8

–6

–12 –10 –8
–6
Log peptide concentration

–12

–10

–8

–6

Average fluorescent
intensity

b
IV9
Strong agonist

300

200
0

400

800

IV9-A4
Weak agonist

400

400

400

IV9-A7
Weak agonist
300

300

200

200
0

400
Time (s)

800

0

400

800

Figure 3 | Strength of stimulation inﬂuences the kinetics of Ca2 þ signalling in CTL. (a) Cytotoxic activity by human 68A62 cell line against HLA-A2 þ
JY target cells is shown. Differences in concentration of strong ILKEPVHGV (IV9) and weak (IV9-A7 and IV9-A4) agonist peptides that are required to
achieve the same extent of speciﬁc target cells lysis by 68A62 cells are marked by arrows. (b) Difference in the kinetics of calcium accumulation in
responding 68A62 CTL stimulated with strong (IV9) and weak (IV9-A7 and IV9-A4) agonist peptides at a high peptide concentration (10  4 M) is shown.
The data are representative from two to ﬁve independent experiments. The results shown on b are based on the analysis of 2,000 T cells.

temperature simplifying the assay procedure and increasing the
accuracy of the measurements. We compared Ca2 þ response at
37 °C, 32 °C and room temperature (22–24 °C). Although the
kinetics of the response was slower at room temperature,
lowering temperature did not signiﬁcantly inﬂuence an optimal
time window for measuring Ca2 þ signal and the ratio of maximal
ﬂuorescence intensity to the background ﬂuorescence (Supplementary Fig. 1). Higher temperature increases leakage of the
ﬂuorophore from labelled cells and boost cell motility. Both
factors signiﬁcantly hinder image analysis, so all quantitative
measurements were performed at room temperature.
To evaluate the capability of the assay to detect T cells whose
TCR binds to its natural ligand with a low intrinsic afﬁnity, we
resorted to IV9-A7 and IV9-A4 variants of a strong agonist
peptide ILKEPVHGV (IV9) recognizable by 68A62 CTL11. All
three peptides bind equally well to HLA-A2, but have different
potency in CTL assay. Compared with IV9, the concentration of
IV9-A7 and IV9-A4 peptides required to achieve similar extent of
speciﬁc target cell lysis was 3 and 4 orders of magnitude higher,
respectively (Fig. 3a). The two weak agonist peptides were still

capable to elicit Ca2 þ ﬂux in the monolayer of 68A62 CTL, but
achieving the maximum of Ca2 þ increase in response to IV9-A7
stimulation was delayed to 10–15 min as compared with IV9 that
induced maximum of Ca2 þ response within 2–3 min following
stimulation (Fig. 3b). The response to another very weak agonist
V9-A4 was barely detectable (Fig. 3b). Importantly, time required
to achieve similar level of Ca2 þ increase induced by weak
agonists was signiﬁcantly prolonged (Fig. 3b). These results
are consistent with previously published data showing that
recognition of a strong agonist ligand results in a very rapid onset
and fast accumulation of intracellular Ca2 þ , while stimulation
with weak agonists signiﬁcantly delays the onset time and induces
much slower accumulation of intracellular Ca2 þ with lower
average magnitude12,13. Furthermore, the delay of the onset time
revealed a poor dependence on the peptide concentration12.
The data presented on Fig. 3b were produced at very high peptide
concentration (10  4 M), that is, conditions at which the
difference in T-cell responses may be diminished. Nevertheless,
the observed kinetics of Ca2 þ accumulation for strong and weak
agonist ligands was clearly different. The difference in kinetics of
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Figure 4 | Breadth of tested peptides and the sensitivity of CaFlux assay. (a) The dynamics and magnitude of calcium response by CD8 þ T cells CER43
stimulated by strong agonist peptide GILGFVFTL (GL9) at various concentrations. (b) The dependence of the sensitivity of calcium response in CD8 T cells
CER43 induced by GL9 peptide ligand diluted in a mixture of non-stimulatory peptides (see ‘Methods’ section for details) at total concentration 10  6 M
and indicated ratios. The data are representative of 2 independent experiments and are based on the analysis of B5,000 cells.

calcium signalling induced by IV9, IV9-A7 and IV9-A4 peptides
correlated with the killing potency induced by the same peptides.
This is in accord with our previous ﬁndings showing that the
magnitude and kinetics of Ca2 þ signalling control the efﬁciency
CTL response14,15.
To determine minimal peptide concentration that is required
to detect speciﬁc T cells, we measured Ca2 þ response in CER43
CTL induced by a strong agonist peptide GL9 at various
concentrations. Figure 4a shows the dependence of the calcium
response by the T cells at peptide concentrations ranging from
10  4 M to 10  9 M. The time courses of Ca2 þ inﬂux were
similar at peptide concentration from 10  4 M to 10  7 M, and
the peptide concentration of 10  8 M appeared to be a minimal
required concentration to induce detectable Ca2 þ response. This
is about one order of magnitude higher than the sensitivity of
speciﬁc lysis of GL9-sensitized target cells by CER43 CTL16–18.
Comparison of 3D plot images illustrating Ca2 þ responses of
the T cells at high (10  4 M) and suboptimal (10  8 M) peptide
concentrations showed that the decrease of the response
magnitude at lower peptide concentration was due to a lower
amplitude of the responses of individual cells, but not due to the
changes in the number of the responding cells (Supplementary
Figs 2 and 3).
Virus infection commonly stimulates heterogeneous population of T cells with speciﬁcity to multiply virus epitope. We next
tested the ability of CaFlux assay detecting T-cell responses to
multiple peptide epitopes restricted by the same allele in one
round of the assay. Each peptide in a mixture of several test
peptides added to the monolayer of T cells isolated from
peripheral blood could function as a cognate peptide for some
T cells, while other peptides would behave as non-stimulatory or
self-like peptides. Because T cells in the monolayer present
peptide to each other, antigenic peptides restricted by different
MHC alleles would function as self-like peptides. To this end, all
T cells that are speciﬁc for each of the tested peptides are expected
to respond to their respective cognate peptides providing that the
concentration of these peptides is sufﬁcient.
We chose Flu-derived peptide GL9 diluted in a mixture of
non-stimulatory peptides (see ‘Methods’ section for details) at
1:10 and 1:100 ratios. We then determined whether the diluted
GL9 was still capable to induce Ca2 þ ﬂux in CER43 T cells. The
number, which deﬁnes the fold excess of non-stimulatory
peptides, is essentially equal to the number of stimulatory
peptides that could be successfully tested in a single round of the
assay. As evident from Fig. 4b, T-cell responses can be readily
4

detected with a 10-fold excess and even 100-fold excess of
non-stimulatory peptides suggesting that up to 100 peptides can
still be tested simultaneously in one round of the assay. The latter
is particularly important for clinical applications. To nail down
which peptide(s) serve as T-cell epitopes for a sample of
polyclonal T cells, multiple rounds of the assay with a smaller
peptide groups and individual peptides have to be carried out.
To evaluate the sensitivity of the assay, we combined CER43
CD8 T cells and irrelevant 115iX HLA-A2 þ CTL at various
ratios and determined the minimal number of responsive T cells
that could still be detected. In these experiments, the CER43 T
cells were utilized as antigen-speciﬁc T cells, while 115iX HLAA2 þ CTL clone utilized as unresponsive T cells. The monolayers
containing only 115iX CTL were served as a negative control. We
usually observed a few false positive cells per imaging ﬁeld
containing 4,000–10,000 cells. The false positive signals were
detected occasionally due to movement of non-adhered cells after
peptide injection or accidental cell burst or transient rise of
intracellular Ca2 þ concentration. The number of false positive
cells slightly increased with time mostly due to the movements of
non-adherent cells. To minimize the assay error, we calculated
the frequency of T cells responding to strong agonist peptide at
3–4 min after injection. The data presented in Supplementary
Table 1 show that as little as 3–5 responding T cells among B104
CER43 CTL per imaging ﬁeld were reliably detected. In
experiments with another CTL clone 68A62, we determined that
o0.1% of antigen-speciﬁc T cells could be reliably identiﬁed
(Supplementary Fig. 4).
Application of the assay. To demonstrate usefulness of CaFlux
assay in measuring the frequency of pathogen-speciﬁc T cells,
we utilized frozen samples of commercially available human
peripheral blood mononuclear cell (PBMC) from healthy donors
with known frequency of T cells speciﬁc for cytomegalovirusderived peptide NLVPMVATV (NV9). The frequency of the
NV9-speciﬁc T cells producing INF-g was determined in
ELISpot assay by the company. Supplementary Table 2 shows
that the frequency of the CD8 þ T cells responding to either
individual agonist peptide NLVPMVATV or ProMix HCMV
speciﬁc peptide pool (Supplementary Table 3) was very similar
despite a signiﬁcant difference in concentration of the individual
peptide alone (10  4 M) or within the peptide pool (6  10  6 M)
during stimulation (Supplementary Fig. 5). We also determined
the frequency of responding T cells in this sample by ELISpot
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Discussion
The CaFlux assay described here detects all T cells that are
capable of responding to productive TCR ligation. Importantly,
measuring the kinetics of Ca2 þ ﬂux provides essential information regarding the efﬁciency of T-cell response, a major factor
that characterizes the quality of the immune response. In contrast
to CaFlux assay, ELISpot assay detects only those T cells
that produce particular cytokines upon TCR stimulation. Another
major difference between CaFlux and ELISpot assays is the time
required for completion of the analysis, that is, few minutes
versus 24–48 h, respectively. Not only does the difference in time
required for measurements matter, but also the incubation of
T cells for 24–48 h in the presence of stimulatory peptides could
result in activation of T cells that initially were unresponsive.
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assay which was very similar to that measured by the CTL
company (Supplementary Table 2). However, the frequency of
CMV-speciﬁc T cells measured by ELISpot assay was about two
times lower (Supplementary Table 2). The most plausible reason
for the observed difference is that ELISpot assay counted only
INF-g producing cells, while the CaFlux assay detects all
responding cells capable to ﬂux Ca2 þ and mount various
functional responses. In addition, terminally differentiated and
exhausted cells could die during lengthy incubation (24–48 h)
before producing enough cytokines to be measured by ELISpot
assay. Results of the tetramer staining revealed a larger frequency
of T cells speciﬁc for NV9-HLA-A2 ligand as compared with
CaFlux (Supplementary Fig. 6 and Supplementary Table 2). The
observed difference could be due to presence of unresponsive cells
such as apoptotic cells, terminally differentiated and exhausted
cells, and also the cells with low level of TCR and/or co-receptor.
We also examined the frequency of CMV-speciﬁc CD8 þ
T cells in frozen samples of PBMC derived from a patient who
has undergone bone marrow transplantation. In this patient,
CMV reactivated on day 22 after the transplantation. The PBMC
sample was taken on day 152 followed transplantation. For the
induction of the response we utilized ProMix HCMV speciﬁc
peptide pools from Thinkpeptides (Supplementary Table 3). The
pool consists of 14 peptides representing the key immunodominant epitopes of human CMV covering 9 of the most relevant
HLA types in human population. We found that the number of
CD8 þ T cells was 25% of initially derived patient’s PBMC as
compared with 10% in healthy donor PBMC. The percentage
of patient CMV-speciﬁc CD8 þ T cells was found to be
4.98±1.42% (mean±s.d., n ¼ 2) or 13,825 responding CD8
T cells per 106 PBMC. This is a very high frequency of the
responding cells that were stimulated by two peptides presented
by one MHC-I allele (HLA-A*01:01) (Supplementary Table 3).
Thus, both parameters were signiﬁcantly elevated as compared
with those in samples of normal donors.
Comparison of the kinetics of CMV-speciﬁc CD8 T-cell
responses in healthy donors and transplant patients revealed
much faster response of the T cells from the donor as opposed to
that from the transplant patient (Fig. 5 and Supplementary
Fig. 7). Distinct response kinetics of healthy donor’s and
the patient’s T cells is also evident from time-dependent
appearance of responding T cells (Supplementary Movies 3
and 4). The kinetics of Ca2 þ signalling triggered by individual agonist peptide NLVPMVATV or ProMix HCMV
speciﬁc peptide pool was found to be very similar (Supplementary Fig. 5 and Supplementary Movie 5). The response of the
T cells from the patient recapitulate the response of CD8 þ T-cell
clone towards weak agonist peptide (see Fig. 3a) suggesting that
the T cells speciﬁc for the tested peptides appeared to be
inefﬁcient.

Positive cells/field
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Figure 5 | Kinetics of calcium response of CMV-speciﬁc CD8 þ T cells.
CMV-speciﬁc CD8 þ T cells from a healthy donor (a) and a patient after
haploidentical stem cell transplantation (b) revealed different kinetics of
Ca2 þ signalling on antigen stimulation. CD8 þ T cells were puriﬁed from
PBMC by negative magnetic sorting and puriﬁed CD8 T cells were labelled
with Fluo-4 and immobilized on a glass surface as described in ‘Methods’
section. The T cells from healthy donor were stimulated by CMV-derived
peptide NLVPMATV at 10  4 M while the T cells from the patient were
triggered with ProMix CMV peptide pool at 9  10  5 M. The images of
responding cells are taken at 720 s after the stimulation. The data shown
are representative of 5 (a) and 2 (b) independent experiments and are
based on the analysis of 4,600 and 4,200 T cells, correspondingly. Scale
bars, 50 mm.

Tetramer19 and dextramer20 binding assays typically detect only
T cells whose TCR recognizes a given pMHC ligands but not
necessarily respond to the ligand. Comparison of CaFlux with
ELISpot and tetramer and dextramer detection of antigen-speciﬁc
T cells is presented in Table 1.
It has to be noted that the assay design assumes that only Ca2 þ
dependent T-cell responses could be detected. Anergic and
exhausted and apoptotic cells could not ﬂux calcium, and
Fas/FasL-mediated T-cell response that may not depends on
Ca2 þ ﬂux21–23. These could preclude detection of tumour-speciﬁc
T cells freshly isolated from solid tumours24. However, our goal is
to detect responses that are linked to the ability of T cells to
exercise functional pathogen and tumour-speciﬁc responses.
We have demonstrated the utility of CaFlux assay for
measuring the frequency of T cells speciﬁc for a set of peptides.
For instance, a set of CMV-peptide epitopes recognizable by
protective T cells are already available, and measuring the
frequency of T cells speciﬁc these peptide epitopes is an
important diagnostic and prognostic parameter. Indeed, we have
evaluated responses of CMV-speciﬁc T cells from a normal donor
and a patient after bone marrow transplantation demonstrating
the ability of the assay to distinguish between T-cell responses of
different quality (Fig. 5). The frequency and quality of pathogenspeciﬁc T cells provide useful information as diagnostic,
prognostic and safety biomarkers, and may serve as a predictor
of clinical outcomes during immunotherapeutic interventions.
Reliable immune monitoring of T-cell responses is also essential
for vaccine development and adoptive T-cell transfer therapy as
well as for analyzing responses against various T-cell epitopes in
normal people to characterize the status of their immune system.
Thus far, we utilized the total fraction of CD8 þ T cells. But it
is becoming evident that various subsets of CD8 T cells exercise
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Table 1 | Comparison of CaFlux with Tetramer and ELISpot assays.
Assay
What is measured

CaFlux
Ca2 þ signalling, a universal
parameter of responding T cells

Tetramer
TCR speciﬁcity

ELISpot
Secreted cytokines

Time of the
parameter measuring

2–3 min (ﬂuorescent microscopy)

2–3 min (Flow cytometry)

24–48 h plus measuring the level
of secreted cytokines in culture supernatant

Functional and unresponsive T cells

T cells producing deﬁned cytokine and
unresponsive T cells that could be activated
during assay accounting for pseudo positive
results

Type of detected CD8 Functional T cells plus the ability to
T cells
evaluate the efﬁciency of T-cell
response
Frequency

A few cells per 104 CD8 T cells

A few cells per 104 CD8 T cells

A few cells per 2–4  105 PBMC*

Antigen-presenting
cells

Not required but can be used

Not required

Required

Number of antigenspeciﬁc peptides per
assay

1–100 peptides restricted by a single Up to 15 peptides
or multiple MHC alleles

Drawbacks

Required CD8 T-cell isolation

10–20 peptides

Requires production of pMHC protein for Detect CD8 T cells producing distinct
each peptide and detects unresponsive T cytokines and may detect initially
cells
unresponsive T cells

*Because the fraction of CD8 T cells in PBMC correspond to 5–10%, the sensitivity of the assay is comparable to pMHC tetramer and CaFlux assays.

distinct functions25–27 and could have different effect on clinical
outcome. To analyze the subsets of the responding cells in CaFlux
assay, magnetic sorting could be utilized to isolate T-cell subsets
and their responses could then be evaluated. Alternatively, the
assay would allow not only measuring Ca2 þ ﬂux in the T cells,
but also staining the cells with ﬂuorescent-labelled antibodies for
cell surface markers to visualize T cells of various phenotypes.
The assay also has potential analyzing responses against various
T-cell epitopes in normal people to characterize the status of their
immune system.
This study provides a foundation for further development and
clinical application of CaFlux assay. In the future, CaFlux assay
could be adapted to characterizing T-cell responses in a course of
autoimmune diseases including measuring the frequency of
pathogenic CD4 þ T cells.
Methods
T cells. HIV- and Flu-speciﬁc human CD8 þ T-cell clones, termed 68A62
and CER43, were kindly provided by Bruce Walker and Antonio Lanzavecchia,
correspondingly. These T cells recognize ILKEPVHGV (IV9) and GILGFVFTL
(GL9) peptides, respectively, both presented by HLA-A2 MHC class I
(refs 14,17,18). 115iX is a CD8 þ T-cell line developed from D3 CTL28–30 as a
result of spontaneous mutation in its TCR b chain resulting in loss of speciﬁcity for
its natural ligand31. This cell line was used as T cells with irrelevant speciﬁcity for
negative control. CTL were stimulated with a mixture of allogeneic irradiated
PBMC and anti-CD3 antibody overnight. IL2 (50–200 units ml  1) was then added
to the culture, and the CTLs were allowed to rest for 12–17 days before the
experiments. Human PBMC from healthy donors with known frequency of
T cells speciﬁc for CMV-derived peptides were supplied by CTL Inc.
Antibodies. Hybridoma producing TS2/4 anti-LFA-1 antibodies was purchased
from ATCC. The antibody was puriﬁed from culture supernatant by afﬁnity
chromatography on protein A Sepharose as described previously18.
Peptides. Tax (LLFGYPVYV) peptide from human T-lymphotropic virus type 1
(ref. 32), SL9 (SLYNTVATL) peptide from HIV Gag p24 protein28,29, MART-1
(ELAGIGILTV) peptide from Melan/MART-1 tumour antigen expressed on
malignant melanoma cells33 and GILGFVFTL (GL9) peptide from the inﬂuenza
matrix protein34 were synthesized by Research Genetics, Inc. ILKEPVHGV (IV9)
peptide from HIV reverse transcriptase11 and the peptide variants (IV9-A4 and
IV9-A7) was a kind gift from Herman Eisen. NLVPMVATV (NV9) peptide from
HCMV pp65 was purchased from CPC Scientiﬁc, Inc. ProMix HCMV peptide pool
containing 14 different HCMV-derived peptides restricted by various MHC
class I alleles was supplied by Thinkpeptides. The pooled HLA-A*0201 and
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HLA-A*0101 restricted peptides are immunodominant peptides. These peptides
bind to respected HLA proteins with high afﬁnity35,36 (also see Large scale analysis
of peptide-HLA-I stability: http://www.iedb.org/refId/1028282).
To prepare non-stimulatory peptide mixture, Tax, SL9, MART-1 and IV9
peptides were combines at equimolar ratio and were utilized as non-cognate
peptides, which did not induce antigen-speciﬁc Ca2 þ ﬂux in CER43 cells.
Magnetic sorting of T-cell subsets. CD8 T cells were puriﬁed from frozen human
PBMC by negative selection using MACS Cell Separation Technology according to
manufacturer instruction (Miltenyi Biotec).
T-cell labelling with calcium indicator. A total of 106 cells in 1 ml of PBS were
loaded with Fluo-4 (Life Technologies) at 2–4 mM for 30 min at 37 °C in the
presence of 0.02% pluoronic acid F-127 and 4 mM probenecid. The cells were
washed free of unreacted reagents and incubated at 37 °C for additional 30 min.
The cells were then resuspended in the assay buffer (20 mM HEPES, 140 mM NaCl,
5 mM KCl, 0.7 mM Na2HPO4, 6 mM D-glucose, 1 mM CaCl2, 2 mM MgCl2 and 1%
HSA) and used for Ca2 þ ﬂux analysis14,37.
Preparation of T-cell monolayers. Glass bottom of 96-well MatTec plates
was treated with 1 M HCL, thoroughly washed with water and covered with
poly-L-lysine (Sigma, molecular weight 4300,000) at 0.1 mg ml  1 for 1 h at room
temperature. After washing with Dulbecco’s PBS (DPBS), TS2/4 non-blocking
mAb speciﬁc for LFA-1 were added to the plate at concentration 10 mg ml  1
overnight & 4 °C. The wells were washed with DPBS, and 3  105 Fluo-4-labelled
T cells in 100 ml of the assay buffer were added to each well. The plates were
centrifugated at 100 g for one minute and were incubated for 30 min at room
temperature before the imaging. The quality of T-cell monolayer was assessed
using bright ﬁeld microscopy.
Measurements of Ca2 þ ﬂux in responding T cells. To identify responding
T cells we imaged T-cell monolayers before (background measurement) and after
(response) addition of stimulatory peptides. The images of T-cell monolayers were
taken at experimentally determined exposure times using Zeiss Axiovert 200 M
inverted microscope equipped with temperature controlled system and Andor Zyla
sCMOS camera and  10 objectives. For CTL clones, the average intensity of
images before and after the T-cell stimulation at various time points were
determined by MetaMorph software. The frequency of responding T cells in
polyclonal populations was also determined by MetaMorph software. First, images
acquired after the stimulation with peptides were subtracted from the background
images. Using the resulting image, the threshold higher than the basal oscillations
was established. Second, background images acquired before T-cell stimulation
were subtracted from images acquired after the stimulation with peptides of
interest to derive images containing responding cells. The latter were subjected to
Integrated Morphometry Analysis to examine a combination of morphometric
parameters such as object size, ﬂuorescent intensity and/or shape to allow singling
out responding T cells. Time-dependence of average ﬂuorescence intensity in the
responding T cells revealed TCR-mediated kinetics of Ca2 þ response. The number
of labelled cells per ﬁeld was counted using Count Nuclei function of the
MetaMorph Premium software.
Cytolytic assay. Lymphoblastoid target cells JY (5  103) were washed, 51Crlabelled and then combined with various amounts of stimulatory peptide of interest in
150 ml R10 (RPMI-1640 containing 10% fetal calf serum). 68A62 or CER43 or 115i in
50 ml in of R10 were then added to ﬁnal assay volume of 200 ml. The assay was
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performed in 96-well round-bottom plates at an effector-to-target ratio of 5:1. The
plates were incubated for four hours in a CO2 incubator at 37 °C and 51Cr release was
measured in 100 ml of supernatant from each well. Per cent speciﬁc lysis was
determined as previously described18,37,38.
IFN-g ELISPOT assay. ELISPOT assay was performed according to the instruction
from manufacturer who supplied ELISPOT assay kit (CTL. Inc.). ELISPOT 96-well
plates were coated with capture antibody against IFN-g overnight at 4 °C. Freshly
thawed PBMC were placed at quadruplicates in the plate at a density 2  105 per well
along with an antigenic peptide at ﬁnal concentration 10  6 M. The stimulation was
performed for 24-hours at 37 °C in CO2 incubator. Plates were washed and developed
using detection antibody against IFN-g, Streptividin-AP and the substrate solution.
The numbers of spots per well were determined using CTL ImmunoSpot analyzer and
CTL ImmunoSpot Software. The ﬁnal data were reported after subtracting the average
response in unstimulated samples.
Quantiﬁcation of antigen-speciﬁc T cells. The fraction of the responding cells
was determined as ratio of the T cells that respond on antigenic stimulation to total
number of antigen-speciﬁc T cells taking into the experiment. Fluo-4-labelled
CER43 cells were mixed with unlabelled cells at ratio 1:10. The cells were plated on
96-well plate to form monolayer. To induce Ca2 þ ﬂux GL9 cognate peptide were
added at concentration 10  4 M. The bright ﬁelds and ﬂuorescent ﬁelds were
acquired before and after addition of the peptide. Each imaging ﬁeld contained
from 50 to 400 labelled cells. The pool of responding cell was found by subtraction
of a background image from the image acquired after peptide addition. The
subtracted image was compared with the background image to identify nonresponding cells. The fraction of responding cells was calculated from three
independent experiments and is equal to 92.8±3.9% (mean±s.d.).
Data availability. All data in this manuscript are available from the authors on
request.
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